• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) BIOCOR VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA) BIOCOR VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number B10-31M
Device Problem Gradient Increase (1270)
Patient Problems Atrial Fibrillation (1729); Dyspnea (1816); High Blood Pressure/ Hypertension (1908)
Event Date 08/15/2017
Event Type  Injury  
Event Description
On (b)(6) 2005, a 31mm biocor valve was implanted in the mitral position in a patient with multiple co-morbidities.On (b)(6) 2017, the patient presented with fatigue, dyspnea, af and peripheral edema consistent with biventricular failure.The patient's pressure was 100/60mmhg and the patient demonstrated extended neck veins indicative of increased venous pressure.A resting ecg was normal and good left ventricular function with an ejection fraction of (b)(4) was noted on echo.Signs of pulmonary hypertension and tricuspid incompetence were present.Pulmonary pressure of more than 60mmhg was observed and severe mitral incompetence was noted on echo.On (b)(6) 2017, the biocor valve was explanted and replaced with a sorin pericarbon more valve.
 
Manufacturer Narrative
The results of the investigation concluded that cusps 2 and 3 contained tears at the stent post, and cusps 1 and 3 were folded and contained inflow fibrous pannus ingrowth and microcalcifications.All three cusps had thinning and loss of collagen fibers on their base.No acute inflammation was found to be present.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.There was no evidence found to suggest the cause of the tears, pannus, folds, microcalcifications or loss of collagen fibers was due to an intrinsic defect in the valve, as supported by the review of the device history record and by the analysis performed.The cause for the reported event remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOCOR VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 34000 -000
BR  34000-000
Manufacturer (Section G)
ST. JUDE MEDICAL BRASIL LTDA. (NOVA LIMA)
caixa postal 106
belo horizonte 34000 -000
BR   34000-000
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key6850098
MDR Text Key85263785
Report Number3001743903-2017-00037
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeSF
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/04/2008
Device Model NumberB10-31M
Device Catalogue NumberB10-31M
Device Lot Number2965286
Other Device ID NumberA10078754
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/16/2017
Initial Date FDA Received09/07/2017
Supplement Dates Manufacturer Received09/11/2017
Supplement Dates FDA Received10/05/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/03/2004
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age79 YR
Patient Weight60
-
-